 |
D3 Bio
Last updated: January 20, 2024
George Chen, CEO
Country: China | Funding: $200M (+)
Website: https://www.d3bio.com/
D3 Bio identifies areas of unmet need in immunology and oncology and use existing clinical data to find precision medicine targets and delivery methods with the potential to improve outcomes.
Website: https://www.d3bio.com/
D3 Bio identifies areas of unmet need in immunology and oncology and use existing clinical data to find precision medicine targets and delivery methods with the potential to improve outcomes.